Table 4

Proportion of participants experiencing clinically relevant improvement, deterioration or change in health markers

Parameter*Classification of changeImprovementNo changeDeterioration
BMIChange≥1.46 kg/m2106 (36.2%)168 (57.3%)19 (6.5.%)
2.79 (2.15 to 4.34)0.20 (−0.30 to 0.80)−2.04 (−2.77 to −1.52)
SGRQChange≥4 units158 (53.2%)127 (42.8%)12 (4.04%)
−18.17 (−26.53 to 9.91)0 (−1.84 to 0)17.01 (10.80 to 19.81)
6 min walk test distanceChange≥26 m142 (53.6%)72 (27.2%)51 (19.3%)
75.28 (49.95 to 102.09)3.48 (−8.23 to 12.85)(−85.96 to −41.23)
6 min walk test desaturation (SpO2 less 92% at end of walk)Change ‘yes’ or ‘no’14 (5.26%)248 (93.2%)4 (1.50%)
Presence of monthly symptomsChange between present/absent monthly symptoms125 (41.5%)166 (55.2%)10 (3.3%)
FEV1 (L)†Change≥100 mL88 (35.8%)85 (34.6%)73 (29.7%)
0.21 (0.15 to 0.31)0 (−0.04 to 0.06)−0.18 (−0.31 to − 0.14)
FVC (L)†Change≥100 mL126 (51.2%)68 (27.6%)52 (21.1%)
0.25 (0.17 to 0.42)0 (−0.03 to 0.05)−0.25 (−0.34 to −0.15)
Unscheduled visit to healthcare for respiratory conditionChange≥1 visit46 (15.4%)246 (82.3%)7 (2.3%)
−1 (−1 to −1)0 (0 to 0)2 (2 to 2)
  • Measure between baseline visit and last visit at 3 years (n=309).

  • *All continuous variable normalised to time (1095 days since baseline measurements).

  • †Matched postbronchodilator spirometry to ATS standards, n=246.

  • BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.